ARCHIVES

NCI Not Following Congress Mandate, Zubrod Contends

This article is from The Cancer Letter archive.

Vol. 04 No. 17 | April 28, 1978

Download PDF Visit The Full Archive

Related Articles

Phase III Tumor Treating Fields Trial Halted Following Positive Results in Interim Analysis

November 28, 2014

NCI-Approved Clinical Trials Listed For January

January 28, 2005

In Brief: Oldham to Leave NCI, Herberman Acting Head Of BRMP; Lansky Appointed Director Of ICC

November 11, 1983

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998

NCI funds four radiation oncology cancer disparities research partnerships.

October 10, 2003

Senate Bill Includes $10 Billion for NIH

February 6, 2009